Quaker Houghton reports Q4 net sales $468.5M (+6% Y/Y); FY2025 net loss $2.5M due to impairment

QUAKER CHEMICAL CORP

2025-FY EPS reported -$0.14 revenue$1,888,634,000

Q4 net income $20.7M ($1.18 diluted EPS); non-GAAP EPS $1.65, up 24% Y/Y.
Full year net sales $1.89B; net loss $2.5M ($0.14 loss per share) includes $88.8M impairment and $35.1M restructuring.
Adjusted EBITDA Q4 $71.9M (+11% Y/Y); full year $299.2M.
Asia/Pacific segment net sales up 15% in Q4; Americas flat, EMEA up 7%.
Generated $136.5M operating cash flow in 2025; returned $75.9M to shareholders via dividends and buybacks.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.